Saut au contenu
Saut au contenu

Évaluation des substances - plan d'action continu communautaire

Évaluation des substances - plan d'action continu communautaire

For each substance, the table shows the evaluating Member State, the year of evaluation and a short description of the concern which led to it being placed on the list.

Community rolling action plan (CoRAP): The community rolling action plan covers three consecutive years and is updated mid of March every year. From this it follows that substances in the table below with the column ‘Year’ indicating a current or future year, are those that have been prioritised for evaluation, and are effectively on the current CoRAP.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information. Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation and CoRAP table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

  • Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
  • CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
  • Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
  • Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
  • Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
  • RCR: Risk Characterisation Ratio
Last updated 10 décembre 2019. Database contains 375 unique substances/entries.
Filter the list
Initial grounds for concern:

 
215-609-9
1333-86-4
2021
France
Carcinogenic
Suspected Reprotoxic
Consumer use
Cumulative exposure
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
215-175-0
1309-64-4
2018
Germany
Carcinogenic
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
200-838-9
75-09-2
2016
Italy
Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
High (aggregated) tonnage
Ongoing
Details
432-240-0
12056-51-8
2017
France
Carcinogenic
Exposure of workers
Information requested
Details
236-675-5
13463-67-7
2018
France
Carcinogenic
Suspected Mutagenic
Other hazard based concern
Ongoing
Details
219-514-3
2451-62-9
2015
Poland
CMR
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
203-002-1
102-06-7
2012
France
CMR
High (aggregated) tonnage
High RCR
Ongoing
Details
204-077-3
115-27-5
2013
France
CMR
Suspected PBT/vPvB
Suspected Sensitiser
Exposure of environment
Exposure of workers
Information requested
Details
701-029-8
-
Estonia
CMR
Sensitiser
Consumer use
Wide dispersive use
Not started
Details
204-278-6
118-79-6
2012
Norway
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
201-289-8
80-54-6
2012
Sweden
CMR
Consumer use
Wide dispersive use
Ongoing
Details
205-743-6
149-57-5
2012
Spain
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
260-828-5
57583-34-3
2015
Netherlands
CMR
High (aggregated) tonnage
Suspended
Details
201-126-0
78-59-1
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
249-204-3
28768-32-3
2013
Denmark
CMR
Wide dispersive use
Information requested
Details
701-276-1
-
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Not started
Details
202-966-0
101-68-8
2013
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Concluded
Details
203-253-7
104-93-8
2012
Ireland
CMR
Consumer use
High RCR
Wide dispersive use
Concluded
Details
205-736-8
149-30-4
2013
Germany
CMR
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-450-8
106-99-0
2014
Germany
CMR
Other exposure/risk based concern
Concluded
Details
202-496-6
96-29-7
2013
Germany
CMR
Sensitiser
Consumer use
Cumulative exposure
High RCR
Wide dispersive use
Concluded
Details
200-843-6
75-15-0
2013
France
CMR
Potential endocrine disruptor
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Follow-up
Details
200-262-8
56-23-5
2012
France
CMR
Exposure of workers
High (aggregated) tonnage
Conclusion under preparation
Details
200-817-4
74-87-3
2012
Italy
CMR
Potential endocrine disruptor
High RCR
Concluded
Details
203-733-6
110-05-4
2016
Netherlands
CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
205-016-3
131-17-9
2013
Spain
CMR
Consumer use
Wide dispersive use
Concluded
Details
201-550-6
84-66-2
2014
Germany
CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
212-783-8
868-85-9
2012
Netherlands
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
200-849-9
75-21-8
2012
Austria
CMR
High (aggregated) tonnage
Concluded
Details
200-001-8
50-00-0
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-626-1
98-00-0
2013
Poland
CMR
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-617-8
123-31-9
2012
Italy
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
206-019-2
288-32-4
2012
United Kingdom
CMR
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
247-722-4
26471-62-5
2012
Poland
CMR
Suspected PBT/vPvB
Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-785-7
99-76-3
2014
France
CMR
Potential endocrine disruptor
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
448-020-2
-
2013
Slovakia
CMR
Suspected PBT/vPvB
High RCR
Concluded
Details
203-777-6
110-54-3
2012
Germany
CMR
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
272-486-4
68855-45-8
2016
France
CMR
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-251-5
-
2013
Netherlands
CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
905-806-4
-
2015
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-825-9
127-18-4
2013
Latvia
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-726-8
109-99-9
2013
Germany
CMR
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-625-9
108-88-3
2012
Finland
CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-800-2
126-73-8
2012
Hungary
CMR
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
242-060-2
18172-67-3
2014
Greece
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-820-9
110-97-4
2013
Czech Republic
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
203-308-5
105-55-5
2019
Poland
Suspected Carcinogenic
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
211-463-5
646-06-0
2016
Germany
Suspected Mutagenic
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
273-227-8
68953-84-4
2013
Germany
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
274-581-6
70356-09-1
2015
Germany
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
202-707-1
98-85-1
2019
Italy
Suspected Carcinogenic
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Ongoing
Details
700-604-0
947701-81-7
Finland
Suspected PBT/vPvB
Consumer use
Not started
Details
203-049-8
102-71-6
2014
United Kingdom
Suspected CMR
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
216-823-5
1675-54-3
2015
Denmark
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
203-872-2
111-46-6
2015
Hungary
Suspected CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
201-236-9
79-94-7
2015
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
204-279-1
118-82-1
2014
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Information requested
Details
247-979-2
26761-45-5
2015
Denmark
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
202-532-0
96-76-4
2017
Belgium
Suspected CMR
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
622-542-2
3891-98-3
2020
Austria
Suspected Mutagenic
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Not started
Details
200-076-7
51-03-6
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Not started
Details
219-470-5
2440-22-4
2016
Czech Republic
Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
203-234-3
104-76-7
2014
Poland
Suspected CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-079-1
103-09-3
2015
Belgium
Suspected CMR
Consumer use
Wide dispersive use
Concluded
Details
629-661-9
83834-59-7
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Information requested
Details
212-782-2
868-77-9
2014
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
200-889-7
75-65-0
2013
United Kingdom
Suspected CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
202-112-7
91-97-4
2013
France
Suspected CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Concluded
Details
242-016-2
18127-01-0
2020
Sweden
Suspected Reprotoxic
Consumer use
Exposure of workers
Wide dispersive use
Not started
Details
204-633-5
123-51-3
2020
Poland
Suspected Carcinogenic
Suspected Reprotoxic
Suspected Sensitiser
Consumer use
Exposure of workers
Not started
Details
219-785-8
2530-85-0
2015
Ireland
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
428-970-4
13595-25-0
2014
Belgium
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Concluded
Details
Bisphenol A; BPA
201-245-8
80-05-7
2012
Germany
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-804-9
99-96-7
2014
Czech Republic
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Concluded
Details
201-618-5
85-60-9
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
202-525-2
96-69-5
2015
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Information requested
Details
283-044-5
84539-55-9
2020
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
271-231-4
68526-83-0
2016
Italy
Suspected Carcinogenic
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Concluded
Details
233-135-0
10043-01-3
2015
France
Suspected CMR
Suspected Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
700-403-8
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Ongoing
Details
232-565-6
9000-90-2
2015
United Kingdom
Sensitiser
Consumer use
Exposure of workers
Concluded
Details
202-860-4
100-52-7
2020
France
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Not started
Details
284-660-7
84961-70-6
2014
Italy
Consumer use
High (aggregated) tonnage
Suspected PBT/vPvB
Wide dispersive use
Information requested
Details
204-337-6
119-61-9
2013
Denmark
Suspected CMR
Consumer use
High RCR
Wide dispersive use
Concluded
Details
931-700-2
-
2021
France
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
203-090-1
103-23-1
2020
Finland
Suspected CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Not started
Details
201-279-3
80-43-3
2015
Norway
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
200-751-6
71-36-3
2017
Hungary
Suspected Reprotoxic
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
201-159-0
78-93-3
2018
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
700-992-1
-
2014
Norway
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
226-394-6
5392-40-5
2015
Sweden
Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-376-6
106-23-0
2015
Sweden
Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
253-775-4
38083-17-9
2014
Belgium
Suspected CMR
Consumer use
Wide dispersive use
Information requested
Details
200-467-2
60-29-7
2020
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
233-072-9
10028-22-5
Lithuania
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
249-044-4
28472-97-1
2013
Italy
Consumer use
High (aggregated) tonnage
Suspected PBT/vPvB
Wide dispersive use
Information requested
Details
214-277-2
1119-40-0
2014
Poland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
212-791-1
870-08-6
2021
Austria
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
215-575-5
1332-77-0
2017
Lithuania
Reprotoxic
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
229-912-9
6834-92-0
2015
Latvia
Suspected Reprotoxic
Consumer use
High (aggregated) tonnage
High RCR
Concluded
Details
405-420-1
-
2020
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
941-303-6
-
2021
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Not started
Details
202-597-5
97-63-2
2014
Italy
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-510-0
96-49-1
2018
Latvia
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-492-7
107-46-0
2013
Norway
Suspected CMR
Consumer use
High (aggregated) tonnage
Information requested
Details
228-408-6
6259-76-3
2012
Netherlands
Suspected CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
938-828-8
-
2020
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
275-702-5
71617-10-2
2016
Germany
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
203-576-3
108-38-3
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
248-666-3
27813-02-1
2014
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
200-659-6
67-56-1
2012
Poland
Suspected CMR
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
201-297-1
80-62-6
2014
France
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
204-317-7
119-36-8
2015
France
Suspected CMR
Consumer use
High (aggregated) tonnage
Follow-up
Details
203-475-4
107-25-5
2018
Latvia
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Exposure of workers
Other exposure/risk based concern
Concluded
Details
203-624-3
108-87-2
2013
Finland
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
700-427-9
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
show/hide
Tangled Multi-Walled Carbon Nanotubes EC / List no: 701-160-0 | CAS no: -
-
-
2019
Germany
Suspected Carcinogenic
Other hazard based concern
Consumer use
Cumulative exposure
Exposure of environment
Wide dispersive use
Ongoing
Details
251-118-6
32588-76-4
2017
Norway
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
225-625-8
4979-32-2
2013
Germany
Suspected CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Exposure of workers
Wide dispersive use
Concluded
Details
214-263-6
1118-46-3
2018
France
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
202-422-2
95-47-6
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
217-421-2
1843-05-6
2013
Italy
Potential endocrine disruptor
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-497-4
107-51-7
2015
Norway
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Follow-up
Details
The complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isononanal. It consists predominantly of C6 olefins and paraffins and C9 alcohols and aldehydes and boiling in the range of approximately 110°C to 202°C (230°F to 396°F).
273-110-1
68938-03-4
2021
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Not started
Details
271-846-8
68609-97-2
2021
Ireland
Suspected Mutagenic
Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Not started
Details
204-407-6
120-55-8
2019
Latvia
Suspected Reprotoxic
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
248-258-5
27138-31-4
2019
Latvia
Suspected Reprotoxic
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
201-280-9
80-46-6
2014
Germany
Potential endocrine disruptor
Consumer use
Wide dispersive use
Ongoing
Details
225-716-2
5026-74-4
2021
Denmark
Suspected Mutagenic
Suspected Sensitiser
Consumer use
Exposure of workers
Not started
Details
203-398-6
106-44-5
2015
United Kingdom
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-396-5
106-42-3
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Information requested
Details
200-752-1
71-41-0
2016
Lithuania
Suspected Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
203-632-7
108-95-2
2015
Denmark
Suspected Mutagenic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
High RCR
Ongoing
Details
284-325-5
84852-15-3
2014
Spain
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
701-266-7
-
2018
Czech Republic
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Conclusion under preparation
Details
231-760-3
7722-64-7
2017
France
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Concluded
Details
202-307-7
94-13-3
2015
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of sensitive populations
Wide dispersive use
Information requested
Details
203-686-1
109-60-4
2021
Ireland
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
905-562-9
-
2020
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
905-588-0
-
2020
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
911-815-4
-
2020
Denmark
Suspected Carcinogenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Cumulative exposure
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
931-384-6
-
2013
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Concluded
Details
701-241-0
-
2020
Italy
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
266-042-9
65997-13-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
264-848-5
64365-17-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
203-585-2
108-46-3
2016
Finland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
231-890-0
7775-14-6
2016
Austria
Suspected Carcinogenic
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
210-382-2
614-45-9
2013
Italy
Sensitiser
Consumer use
Wide dispersive use
Follow-up
Details
246-563-8
25013-16-5
2015
France
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of sensitive populations
Wide dispersive use
Suspended
Details
260-830-6
57583-54-7
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
231-302-2
7488-55-3
2016
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
Information requested
Details
214-685-0
1185-55-3
2013
Sweden
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
204-112-2
115-86-6
2017
France
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
202-908-4
101-02-0
2013
United Kingdom
Suspected CMR
Potential endocrine disruptor
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-028-2
-
2013
France
Suspected PBT/vPvB
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
203-545-4
108-05-4
2019
Latvia
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
215-535-7
1330-20-7
2020
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
215-222-5
1314-13-2
2017
Germany
Other hazard based concern
Consumer use
Exposure of environment
Other exposure/risk based concern
Wide dispersive use
Information requested
Details
215-150-4
1306-38-3
2020
Germany
Suspected Carcinogenic
Suspected Mutagenic
Other hazard based concern
Cumulative exposure
Exposure of environment
Wide dispersive use
Not started
Details
202-870-9
100-61-8
2021
Poland
Suspected Carcinogenic
Suspected Mutagenic
Cumulative exposure
Exposure of workers
High RCR
Wide dispersive use
Not started
Details
205-031-5
131-57-7
2014
Denmark
Potential endocrine disruptor
Cumulative exposure
Exposure of environment
Exposure of sensitive populations
Exposure of workers
Wide dispersive use
Ongoing
Details
262-975-0
61788-44-1
2014
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Cumulative exposure
Ongoing
Details
306-832-3
97416-84-7
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
206-022-9
288-88-0
2015
Belgium
Suspected CMR
Other hazard based concern
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
203-812-5
110-88-3
2013
Poland
Suspected CMR
Suspected PBT/vPvB
Suspected Sensitiser
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
258-904-8
53988-10-6
2018
Germany
Potential endocrine disruptor
Exposure of environment
Ongoing
Details
262-872-0
61617-00-3
2018
Germany
Potential endocrine disruptor
Exposure of environment
Ongoing
Details
219-372-2
2425-85-6
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
220-562-2
2814-77-9
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
926-564-6
-
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
211-989-5
732-26-3
2017
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
203-614-9
108-77-0
2017
Poland
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Concluded
Details
228-768-4
6358-31-2
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
229-355-1
6486-23-3
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
229-419-9
6528-34-3
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
1 - 4.5 moles ethoxylated
500-082-2
32492-61-8
2021
France
Suspected Mutagenic
Potential endocrine disruptor
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
266-733-5
67584-55-8
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Concluded
Details
241-527-8
17527-29-6
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Information requested
Details
218-407-9
2144-53-8
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Information requested
Details
435-790-1
297730-93-9
2018
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Ongoing
Details
215-925-7
1453-58-3
2018
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of environment
Wide dispersive use
Ongoing
Details
202-653-9
98-29-3
2018
Poland
Suspected Mutagenic
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Exposure of environment
Exposure of workers
Concluded
Details
422-040-1
426218-78-2
2016
Spain
Suspected PBT/vPvB
Exposure of environment
High RCR
Information requested
Details
458-680-3
797751-44-1
2019
Spain
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
204-820-1
127-06-0
2016
Austria
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of environment
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
800-353-8
1379524-06-7
2016
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
High RCR
Wide dispersive use
Concluded
Details
480-310-4
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Ongoing
Details
700-242-3
62037-80-3
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
700-323-3
908020-52-0
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
-
-
2018
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Ongoing
Details
270-128-1
68411-46-1
2016
Germany
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
202-394-1
95-14-7
2016
Germany
Potential endocrine disruptor
Exposure of environment
Information requested
Details
218-487-5
2162-74-5
2021
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
421-450-8
154702-15-5
2015
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
247-426-5
26040-51-7
2019
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Ongoing
Details
203-372-4
106-20-7
2019
Portugal
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
700-183-3
52299-25-9
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Concluded
Details
245-366-4
22984-54-9
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
218-747-8
2224-33-1
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
203-629-0
108-91-8
2016
Belgium
Reprotoxic
Exposure of environment
High (aggregated) tonnage
Concluded
Details

Export search results to:

Categories Display

Marqué en tant que:

(cliquer sur le marqueur pour rechercher le contenu pertinent)


Route: .live1